Development and Characterization of Trinitrophenyl-Specific L3T4+ T-Cell Clones  by Shimada, Shinji et al.
Development and Characterization of 
Trinitrophenyl-Specific L3T4 + T-Cell Clones 
Shinji Shimada, M .D., Ph.D. , Ron ald H. Schwartz, M .D., Ph .D ., and Stephen 1. Katz, M .D., Ph .D. 
Dermatology Branch, National Cancer Institu te (SS, SIK), and Labo ratory of Immunology, National In stitute of All ergy and 
In fectious Diseases (RH S) , National Institutes of Hea lth , Bethesda, Maryland , U.S .A. 
Two antigen-specific, L3T4 + , Lyt-2 - T-cell clones have 
been developed from (C57BLl6 X C3H / H eN) F, mice 
epicutaneously sensitized to trinit rochl orobenzene. Genetic 
mappin g and antibody blocking studies demonstrated that 
both of these clon es have specificity for trinitropheny l in 
association with E~: E~ or E3: E~ la molecules . One of 
T he develo pment ofT- ce il cloncs has g rea tl y contr ib-uted to o ur und erstanding of T -ccll activation and o th er T-ce ll funct io ns [1] . The cl ones represent a po p-u lation of T cell s with a sin gle an tigen-specific re-cepto r. M ost of th e T-cell clones that have been de-
veloped to date have demonstrated specifi city for so lu ble pro tein 
antigens, o r fo r :1 11 0 - or autoa nti gens encoded by th e major hi s-
toco mpatib il ity complex (MH ). Som e of th ese cl o nes , as w ell 
as so m e T-cell h ybridomas, have du al specifi city, i.e., they ex hibit 
specifi city fo r both a solubl e pro tein anti gen and an all oa ntigen 
[2,3J. 
T wo of the major sys tem s used in vivo and in vitro for studyin g 
cellular events invo lvin g the skin are hapten-specific conta ct hy-
persensitivity and T-cell activatio n b y haptenated cell s [4J . We 
attempted to develop hapten-specifi c T-cell clones in order to 
faci litate o ur studies of the antigeni c signals req uired for activation 
of T cells. We report the development of two L3T4 ··, hapten-
specifi c T-cell clones, one of w hi ch has a dual specifi city in th at 
it also recogni zes an alloa nti gen on nonhaptenated cells. These 
clones sho uld be useful in assessin g th e anti gen-presentin g ca-
pacity of haptenated self-a ntigens and in furth er elu cidatin g the 
req uirements fo r " processing" of haptenated anti gens. 
MATER IALS AND M ETH ODS 
Animals C3H/HeN , C57BLl6, and (C3H/HeN X C57BLl6)F, 
(BCF,) m ice were obtained from C harl es River Labo ratory, W il-
min gton, M assachusetts. C57BLllO, BlO.BR, B10.A , and BlO.02 
mice were obtained from Jackson Laboratory, Bar H arbor, M aine. 
BI0.A(4R): B10.A(5R), BIO.S(9R) , B10.A(18R) , B1O.MBR, and 
BlO.S mice were produced at the NIH from breed in g pairs orig-
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Abbreviations: 
EC: epiderm al cells 
FCS: feta l calf serum 
IL-2: interlcukin 2 
MH C: major histocompatibility co mplex 
SC: spleen cells 
T NB S: trinitrobenzen e sulfonic acid 
T NCB: trinitrochlorobcnzenc 
TNP: trinitropheny l 
the clones (D-8) also recognizes nonhaptenated cell s ex-
pressing E~: E~. Th ese clones should prov ide useful tools 
fo r the assess ment of the signals reg uired for triggerin g 
immune res ponses to haptcnJted self antigens. J !rlllesl D e/,-
rnalo/ 87:24-29, 1986 
in all y provided by Dr. J ack Stil11pfling, M cLau g hlin Resea rch 
In stitute, G reat Falls, Monta na. A . SW and A. TL mice w ere o b-
tained fro m Dr. A. Kru isbeek (NCI , Bethesda, M aryland). 
Antibodies Ascites containing anti-A~/' (10.2. 16) antibody, and 
anti-Ef.l: E" antibody (14.4.4 anti-En and 17.3.3 a nti-E~·b. ' : En, gifts 
of Dr. David Sachs, Immu no logy Branch, N C I) we re used. 
Y -17 (a nti-Et·b., : E,,) was a g ift of Dr. Ethan Lern er, Ya le Uni-
versit y, N ew H aven , Conn ecti cut; 39G and 40K (anti_ E~·b . s : En) 
were g ifts of Dr. Mi chel Pierres, Centre d ' lmmLlno logie de Mar-
seille- Luminy , Marseille, France. Flu orescein-conjuga ted anti-T hy-
1, anti-Lyt-1 , and anti-L yt-2 ant ibodies were obtai ned fro m Bec-
ton- D ickinson (M oun tain View, Ca lifo rnia). Mo noclonal an ti-
Lyt-2 ant ibod y (fo r cell killin g) was obta ined fro m N ew E ng land 
Nuclear (Boston, Massachu setts). Anti-L3T4 (GK 1. 5. a g ift of 
Dr. Ethan Shevach , Laboratory of Immunolog y, N IA ID , B e-
thesda, Maryland) , first described by Dia lynas et 31 [5], and 
KJ16.1 33. 18 (anti-T cel l recep to r V f.l all o type), described by Has-
kins et al [6], were used as first steps in an indirect immuno flu-
o rescence assay. 
Sensitization of Animals and Development of Trinitro-
phenyl (TNP)-Specific Clones Seven percent (v /v) trini-
trochloro benzene (TN CB, ICN Pharmaceuti ca ls In c. , Pl ain view, 
N ew Yo rk) in acetone:oli ve o il, 4:1, was appl ied to shaved ab-
dom inal skin ofBCF, mice. Four days late r dra il] in g lymp h nodes 
were dissected , teased. and mad e in to sing le cell suspensio ns. 
T hese lym ph node cell s were passed through a G 10 co lumn [7] 
fo llowed by a nylon wool co lulTln [8J. T he emergin g T ceJl-
enriched populatio n was then incubated w ith 1 0.2. 16 (a nti-A ~) 
antibody (1 : 50 diluti o n) at 4°C fo r 30 min, was hed, and incubated 
w ith a 1 : 15 diluti o n of youn g rabbit serum (as a source of C0 111-
plem ent) at 37°C for 45 min. 
The resultant purified T cell s were cultured at 3 x 106 cells/well 
w ith 3 x 106 C3 H / !-IeN hapten-co upled spleen cells (SC) per 
well in 24-wel l Linbro plates (Flow Labora tory) in a tota l volume 
of2 ml of E HAA (C lick's) m edium (M . A. Bio produ cts) su pple-
mented w ith 2 mM L-g lu tam ine, 100 U / ml peni cillin , 100 p.g/ml 
strepto m ycin ,S X 10 - 5 M 2 Ille rca ptoethanol, and 10% hea t-
inacti va ted bovine feta l calf serum (FCS) (B io fluid s). 
A ftel" 4 cia ys of culture, the ce ll s were harves ted, appli ed onto 
a Fi coll-Paq ue densi t y g radient, and centrifuged to obtain a lym-
phob last-rich T-cell fra ction . These celJs were then cultured (rested) 
for 5-9 days w ith no nh aptenated C3H / HeN S . After 2 cycles 
of st imulation (wi th hapten-coupled SC) and restin g, the cells 
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were depleted of Lyt-2 + cells by trea tment with anti-Lyt-2 an-
tibody (1: 500 dilution) plus complement (rabbit serum, 1 : 15 di-
lution). After restin g for 7 days, T cells were restimulated and 
cloned by limiting dilution (0.3 cells / well) in 96-well flat-bottom 
Costar plates. Haptenated SC (TNP-SC) (3 X lOS) and 10% 
interleukin 2 (IL-2) (Collaborative Research , Lexington, Massa-
chusetts) were added to each well. Colonies that were identified 
in a well were harvested and expanded into 24-well flat-bottom 
Linbro plates initially in the presence of IL-2. With further ex-
pansion, IL-2 was o mitted . 
Hapten Coupling For hapten coupling, SC were washed 3 
times in Hanks ' balanced salt solution, and then incubated with 
5 mM of trinitrobenzene sulfonic acid (TNBS, sodium salt, Sigma 
Chemical Co., St. Louis, Missouri) for 10 min at 37°C. The cells 
were then washed 3 times with RPM I 1640 containing 10% FCS. 
In some experiments the concentration of TNBS used for cou-
pling was reduced to 1, 0.1, 0.01, or 0.001 mM. 
Proliferation Assay After resting for 7-12 days with nonhap-
tenated C3H/HeN-SC or B6-SC, 104 T cells /well were cultured 
with SC (which were hapten coupled with 1 mM TNbS) from 
various strains of mice for 64-70 h in 0.2 ml of supplemented 
EHAA medium at 37°C in a 5% CO2 atmosphere. eH]dThd 
(1 fLCi) was added for the last 16-18 h; cells were harvested with 
the MASH (M.A. Bioproducts) and the radioactivity incorpo-
rated was measured by f3 scintillation counting techniques . An-
tibody blocking of proliferation was tes ted by adding various 
antibodies to the culture . Monoclonal antibodies in ascites form 
were added at a final dilution of 1 : 500, and purified antibodies 
were added at a final concentration of 20-40 fLg/ml. 
Determination of Cell Surface Phenotype by Immuno-
fluorescence The T-cell clones were propaga ted as described 
above and then depleted of stimulator cells by Ficoll-Paque sed-
imentation. Aliquots ofl06 cells were incubated with fluorescein-
conjugated anti-Thy-1.2 (1 : 100), anti-Lyt-l (1: 50) or anti-Lyt-2 
(1 : 50) antibodies for 45 min at 4°C, washed 4 times in cold 
phosphate-buffered saline, and viewed under an epi-illumi-
nated fluorescence microscope. For L3T4 and KJ 16.133.18 stain-
ing, the cells were incubated with the antibodies for 30 min at 
4°C, washed 3 times, and then incubated with fluores cein-con-
jugated antirat IgG antibody. 
RESULTS 
Generation of TNP-Specific Proliferating T-Cell Clones 
D-8 and SE-4 After repeated stimulation oflymph node T cells 
from TNCB-sensitized BCF, mice, the cells were depleted of 
Lyt-2 + cells by treatment with anti-Lyt-2 antibody and comple-
ment and were cloned by limiting dilution. We obtained clone 
D-8 which proliferated preferentially to TNP C3H-SC and TNP 
C3H-epidermal cells (EC) as opposed to nonhaptenated C3H-SC 
or C3H-EC (Table I). Subsequently a second clone (SE-4) with 
specificity for TNP was developed (Table II) . N either clone pro-
liferated in response to fluores cein isothiocyanate-coupled cells or 
required exogeneous IL-2 to prolifera te (data not shown). Re-
sponses to TNP-SC were greater than to TNP-EC on a per cell 
basis (Table I) . 
Phenotype of Clones D-8 and SE-4 Cell sur["ce markers of 
D-8 and SE-4 are identical as determined by immunofluorescence. 
They are Thyl +, Lyt-1 +, Lyt-2 - , L3T4 +, KJ16 .133.18 +. 
Genetic Restriction of D-8 and SE-4 As shown in Table II, 
D-8 cells responded to TNP C3H, TNP BlO.BR, TNP BI0.A, 
and TNP BlO.MBR, but not to TNP B10.A(4R) sc. 0-8 also 
proliferated in response to TNP B10.A(5R), to TNP B10.S(9R) , 
and even to BlO.S(9R) SC that had not been coupled with TNBS 
(Tables II, Ill) . It was not reactive to B10.S SC, thus eliminating 
the possibility that the alloreactivity is to A~: A! (Tables Ill , IV). 
From these studies the restriction element for the hapten speci-
ficity of this clone appears to be E~:E~ or E3:E~ (Table IV). The 
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Table I. Proliferative Response of Clone 0-8 to 
Trinitrophenyl (TNP)-Coupled Spleen Cells and TNP-Coupled 
Epidermal Cells 
Stimulator Cells 
Clone 0-8 
Type' Number Proliferative Responseb 
0 286 ± 43 
TNP C3H-SC 2 X 10" 45,365 ± 6,098 
1 X 106 91,904 ± 15,012 
3 X 105 51 ,882 ± 10,800 
I X 105 30,930 ± 1,003 
3 X 104 9,533 ± 1,623 
1 X 104 958 ± 406 
3 X 103 682 ± 415 
TNP C3H-EC 1 X 10" 590 ± 285 
3 X 105 8,347 ± 724 
1 X 105 5,160 ± 1,383 
3 X 104 625 ± 213 
1 X 104 305 ± 32 
3 X 103 291 ± 35 
I X 103 255 ± 49 
C3H-SC 3 X 105 434 ± 37 
C3H-EC 1 X 105 474 ± 161 
"SC = spleen cells. EC = epidermal cells. 
bl3H]dThd incorporation in cpm :!: SEM. 
clone is also alloreactive to E~: E~. Subclones of D-8 showed the 
same specificities (Table III) . The clone SE-4 had almost the. same 
specificity except that it did not respond to B 10. S(9R) without 
TNP (Tables II-IV) , i.e., it was not alloreactive. D-8 and SE-4 
thus have different fin e specificities. 
Blocking of T-Cell Proliferation of D-8 and SE-.4 by Anti-
Ell: E", Monoclonal Antibodies To further determl11e whether 
the E/3: E" molecule is the restriction element for O-S and SE-4, 
we attempted to block prolifera tion by using various anti-E/3: E" 
monoclonal antibodies . With regard to 0-8, when TNP B10.A 
SC or TNP BlO.A(5R) SC were used as stimulators, all of the 
anti-E/3:E" monoclonal antibodies (14.4.4, 17.3.3, Y-17, 39G, 
40K) blocked T-cell proliferation (Table V). 10.2.16, which is 
anti-A~ did not block T-cell proliferation. In assaying clone SE-
4, the same pattern of blocking was obser~;~ a~ with D-S. These 
results demonstrate that for both clones E/3 : E" IS the restnctlon 
element recognized in association with TNP. 
Table II. Genetic Restriction of Clones 0-8 and SE-4 
Proliferative Response" 
Stimulator Cells 
o 
TNP C3H" 
TNP Bl0.A(18R) 
TNP Bl0.BR 
TNP Bl0.A 
TNP Bl0.MBR 
TNP BI0.A(4R) 
TNP BI0.A(5R) 
TNP BlO.S(9R) 
TNP BI0.D2 
C3H 
BI0.A(18R) 
BIO.BR 
BlO.A 
B1O.MER 
Bl0.A(4R) 
BlO.A(5R) 
BI0.S(9R) 
BlO.02 
0-8 
256 ± 46 
70,064 ± 26,692 
451 ± 187 
74,328 ± 8,881 
77,536 ± 1,082 
93,943 ± 8,745 
196 ± 38 
28, 442 ± 3,879 
196,778 ± 37,417 
130 ± 53 
484 ± 93 
218 ± 12 
247 ± 107 
200 ± 23 
475 ± 102 
324 ± 45 
626 ± 243 
97,307 ± 11,830 
412 ± 72 
"[3H]dThd incorporation in cpm :!: SEM. 
bSpleen cells (1 06) used as stimulators. 
SE-4 
316 ± 182 
26,804 ± 16,665 
433 ± 35 
120,925 ± 9, 221 
143,956 ± 16,845 
224,270 ± 19,488 
172 ± 24 
26,217 ± 249 
16,929 ± 2,352 
101 ± 17 
780 ± 258 
372 ± 25 
326 ± 118 
278 ± 74 
405 ± 103 
678 ± 127 
310 ± 91 
417 ± 159 
338 ± 90 
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Table III. Genetic Restriction of Subclones of 0 -8 
Stimulator Cells 
0 
TNP C3 Hb 
TNI' B10' 
TNP B10.A 
TNP B10.A(4R) 
TNP B10.A(5R) 
TNP BlO.S(9R) 
TNP B10.S 
TNP A.TL 
TNP B10.D2 
TNP A.SW 
C3H 
B10.A 
Bl0.A(5R) 
Bl 0.S(9R) 
A.TL 
"I' l-IldThd incorpor;ltion in cpm :!: SEM. 
"Spleen cell s (10') used as stimulators. 
Clone D-8" 
192 ± 63 
115,038 ± 4,195 
11 4 ± 9 
30,797 ± 426 
153 ± 24 
65,722 ± 7,807 
98,273 ± 17,062 
201 ± 52 
60,975 ± 2,330 
130 ± 53 
189 ± 69 
596 ± 54 
247 ± 58 
298 ± 53 
107,083 ± 8,009 
497 ± 125 
Subclones 
8-1 8-2 
137 ± 23 148 ± 69 
137,076 ± 8,663 69,363 ± 12,254 
197 ± 23 121 ± 27 
69,428 ± 9,161 24,130 ± 5,783 
292 ± 116 207 ± 19 
111,055 ± 3,932 11,622 ± 5, 106 
11 6,890 ± 5,960 49,731 ± 7, 148 
282 ± 94 254 ± 66 
11 4,967 ± 13,850 37,106 ± 26 
117 ± 39 213 ± 58 
158 ± 43 175 ± 87 
691 ± 102 579 ± 35 
203 ± 68 228 ± 44 
230 ± 77 309 ± 24 
106,752 ± 2,940 69,665 ± 5,355 
217 ± 27 342 ± 19 
'The e10nes or subelones did not proliferate in response to non TNP-coupled cells from BIO, BI0.A(4R). BIO.S. A.SW. or B10.D2 mice. 
When B 10. S(9R) SC were used as aBogeneic stimulator ceBs 
for the D-8 clone, 14.4.4 blocked proliferation, but 17.3.3, 
Y-17, 39G, and 40]( did not. However, a mixture of 17.3.3, 
Y -17, and 39G did block proliferation; 10.2.16, which can rec-
ognize Ah did not block, sugges ting that the aBoreactivity was 
not directed against a hybrid Ah:E~ molecule [1 0J. We conclude 
from these studies that the aBoreactivity of clone 0 -8 is most 
likely directed against determi nants on Eh: E~, although the reason 
w hy a combination of monoclonals is required for blocking is 
not clear. 
Proliferative Responses of D-8 and SE-4 to Varied Con-
centrations ofTNBS Coupled to SC To determine w hether 
limited amounts of TNBS coupled to SC cou ld stiB elicit prolif-
era tion of these clones, SC were co upl ed w ith concentrations of 
TNBS rang in g from 0.001-5 mM. For Bl0.A SC, hapten cou-
pling w ith as low as 0.01 mM TNBS resulted in stimulator cells 
capable of inducing a m aximum proliferative response (Table VI). 
As little as 0 .001 mM was su fficient to induce a significant pro-
li ferative response . In the case of BI0.A(SR) SC, the m aximum 
response could be achieved after couplin g w ith as low as 0.1 mM 
TNBS and 0.01 mM was sufficient to induce a proliferative re-
sponse. These results suggest that the reactive site(s) on the cell 
surface molecules involved in the anti genic determinant(s) must 
be read ily access ible to TNBS. 
DISCUSSION 
The develop m ent of antigen-specific T - ceB clones has fac ilitated 
the study of many types of cellul ar immunologic functions. Our 
interest in hapten-specific clones is based on our ongoing studies 
of the m echan isms invo lved in the induction and expression of 
contact sensitivity. We have previously developed 2 hapten-spe-
cific IL-2-dependent, Lyt 2 + cytotoxic T-ceB clones [l1J which 
preferentiaBy respond to TNP-EC rather than to TNP-SC, but 
whi ch have, to date, f.1 iled to exhibit any in vivo function . The 
T-cell clones described in this stud y (0-8 and SE-4) are of even 
greater potential interest with regard to contact sensiti vity as 
Lyt-2 - helperlinducer clones have been shown to induce delayed-
type h ypersensiti vity in vivo [12J . Thus cloned cells of the 
helperlinducer phenotype would potentially be able to induce 
contact hy persensitivity. Studies to add ress this issue are ongoing. 
Both clones we developed recognize trinitrophenylated class II 
m olecu les 011 SC and EC and one of these clones (0-8) is also 
reacti ve w ith MHC - encoded alloantigens. From our genetic map-
ping and antibody blocking studies we know that the 0-8 clone 
Table IV. Genetic Res triction of Trin itrophenyl-Specific T-Cell C lones 0-8 And SE-4 
MH C Alleles 
K A~ A" E" E" S D D-8 SE-4 
C3H k k k k k k k +" + 
Bl 0.A(18R) b b b b (W b d 
Bl0.BR k k k k k k k + + 
B10.A k k k k k d d + + 
Bl0.MBR b k k k k k q + + 
BIO.A(4R) k k k k (b) b b 
B10.A(SR) b b b b k d d + + 
B10.S(9R) 5 k d d + ' + 
B10.S s s 5 (5) S s 
A.TL 5 k k k k k d + + 
A.SW 5 5 S S (5) 5 5 
BIO.D2 d d d d d d d 
C57BLl6 b b b b (b) b b 
C57BLl10 b b b b (b) b b 
'Response of e10nes to trinitrobenzine sulfonic acid-coupled spleen cells. 
' Parentheses indicate Ep:E" molecules arc not expressed because of deletion of part of the E" b/. gene in these stra ins [91. 
'0-8 is also allorcactive for BtO.S(9R). 
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Table V. Effect of Various Anti-Class II Antibodies on Pro lifera tive Responses of C lones D-8 and SE-4 
Stimulators 
o 
T NP mO.N 
TNP BI0.A(5R) 
" 
BI0.S(9R) 
" 
Bl0.A 
Bl0.A(5R) 
II Antibodies used and dilutions or concentrations. 
' [' HldThd incorpora tion in cpm ± SEM. 
,Spleen cells (106) used as stimulators. 
Antibodies" 
None 
14.4.4 (1:500) 
17.3 .3 (1:500) 
Y-17 (32 /Lg/ml) 
39G (20/Lg/ml) 
40]( (20 /Lg/ml) 
10.2.16 (1:500) 
None 
14. 4.4 (1:500) 
17.3.3 (1 :500) 
Y-17 (32 /Lg/ml) 
39G (20 /Lg/ IllI) 
40]( (20 /Lg/1ll1) 
10.2. 16 (1:500) 
None 
14.4.4 (1:500) 
17.3.3 (1:500) 
Y-17 (32 /Lg/ml) 
39G (20 /Lg/1ll1) 
40]( (20 /Lg/ IllI) 
10. 2. 16 (1 :500) 
17. 3.3,Y -17 ,39Gd 
None 
None 
0 -8" 
199 ± 45 
88,778 ± 9,922 
152 ± 25 
1147 ± 605 
7703 ± 305 
216 ± 57 
228 ± 47 
85,962 ± 3,241 
132,936 ± 21,513 
220 ± 79 
432 ± 58 
3,539 ± 1,983 
84 ± 14 
200 ± 47 
129,533 ± 19,379 
141,800 ± 30,580 
7,780 ± 346 
168,526 ± 1,292 
129,656 ± 11,741 
149,906 ± 3,403 
141,161 ± 17, 175 
137,604 ± 14, 119 
2,977 ± 478 
173 ± 5 
214 ± 58 
11 0 ± 35 
55,000 ± 4,99 1 
1,285 ± 33 
2,237 ± 23 1 
21,283 ± 3,439 
378 ± 77 
374 ± 22 
55,029 ± 3,425 
62,952 ± 2,758 
423 ± 204 
206 ± 83 
11 4 ± 22 
226 ± 82 
56, 187 ± 4,072 
236 ± 56 
176 ± 44 
235 ± 62 
JThe mixture contained the following fi nal concentrations of an tibod ies: 17.3.3 (1: 1500), Y-17 (11 J.Lg/ml ). 39G (7 J.Lg/ l11l). 
recognizes TNP in assocIatIOn with both E~; E~ and E~; E~ 
and cross-reacts with nonhaptenated antigen-presentin g cells that 
express E~; E~. TNP derivatiza tion of cells expressing E~ : E~ 
did not significantly improve their stimulatory potency (Table 
Ill) . This suggests that clone D-8 does not recognize TNP in 
association with E~; E~ . Thus it is tempting to speculate that 
D-8 recognizes TNP-substituted residues on E~ and E~ at sites 
where E~ differs from the former molecules. 
Several investigators have demonstrated , in mi ce, that various 
class I and class II molecules can be directly coupled with TNBS 
[1 3,14]. In this regard, recent studies have determined the nu-
cleo tide sequen ces of m ouse E~, E~ , and E~ genes [15 ,16]. T he 
derived protein seq uences of each of th ese differ only slig htly as 
compared to the sequence of the Eg molecule [15 ,16]. Since TNP 
is most reactive with the amino acids, lysine, tyrosine, and cys-
teine [17], it may be that TNP coupled to amino acids 12, 13, or 
72 of Ell is recognized by the D-8 clone. This is because in the 
E~ m olecule there are substitutions at these positions for either 
cysteine or lys ine (Table VII). Although other differen ces exist 
between E~ and E~/b, taking into account the 110nreactivi ty of 
Table VI. Proliferative Response of Clones D-8 and SE-4 to Spleen Cells Coupled w ith Various Concentrations of 
Trinitrobenzene Sulfonic A cid (TNBS) 
Number 
mM Concentration of TNBS Used for Hapten Coupling 
Clone Stimulator Cells 5 0.1 0.01 0.001 
0-8 Bl0.A 2 x 106 87,912" 98,044 164,577 139,941 13,074 
1 x 106 191,495 191.848 188,194 190.514 10,505 
3 x 105 142,724 197,120 121,621 57,984 528 
1 x 105 7,890 41,906 5, 168 2,1 40 281 
3 x 10' 301 2,678 505 326 302 
Bl0.A(5R) 2 x 106 64,799 92,223 134,428 14,917 237 
1 x 106 138,218 145,628 143,846 17,734 280 
3 X 105 177,843 182,546 38,328 2,283 248 
1 x 105 55,105 45 ,375 1,802 525 318 
3 X 10' 1,494 1,058 154 320 154 
SE-4 Bl0.A 2 X 106 27,328 24,597 48,224 52,965 2.754 
1 x 106 44,475 50,014 71,180 66,094 832 
3 X 105 52,194 84,232 39,790 4,044 195 
1 X 105 21,421 32,095 3,336 464 187 
3 x 10' 3,654 6,280 193 231 264 
Bl0.A(5R) 2 X 106 17,095 25,446 39,672 14,707 1,334 
1 X 106 38,238 40,760 50,810 16,429 474 
3 X 105 24,347 45,414 6,428 1,220 212 
1 X 105 3,008 5,519 408 394 218 
3 x 10' 177 403 156 310 269 
' [' H)dThd incorpora tion in cpm. 
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Table VII. Amino Acid Sequences of Selected Regions of 
Various Ef3 Polypeptide Chains 
Amino Acid Ef3' E/ E{Jb E{Jd 
10 Glu Glu Glu Glu 
11 Tyr Tyr Tyr Tyr 
12 Sel"" Cys Cys Val 
13 Thr Lys Lys Thr 
14 Ser Ser Ser Ser 
15 Glu Glu Glu Glu 
16 Cys Cys Cys Cys 
30 Arg Arg Arg Arg 
31 Tyr Tyr Tyr Phe 
32 Phe Phe Phe ~ 
33 Tyr Tyr Tyr Tyr 
34 Asn Asn Asn Asn 
68 Phe Phe Phe Ile 
69 Leu Leu Leu Leu 
70 Glu Glu Glu Glu 
71 GIn GIn GIn Asn 
72 ~ Lys Lys Ala 
73 Arg Arg Arg Arg 
74 Ala Ala Ala Ala 
75 Ala Glu Glu Ser 
76 Val Val Val Val 
77 Asp Asp Asp Asp 
78 Thr Thr Thr Thr 
79 IY.!: Val Val IY.!: 
80 Cys Cys Cys Cys 
' Underlined amino acids differ from those in E/ and Ef3b [15 ,16]. 
D-S with TNP-E3: E~ (Table IV), there are no other potential 
TNP reactive sites. 
Studies utilizing limited amounts ofTNBS for coupling (Table 
VI) sugges ted that it is TNP coupled to the most highly reactive 
amino acids of Ef3 which would constitute the determinant. Such 
groups usually are exposed to solvent. One would expect the 
same to be true for the determinants recognized by T cells. In 
this regard, the areas of the Ia molecules around positions 12, 13, 
and 72 have been shown to be hypervariable [is] and the site 
around 72 has been shown by naturally occurring [19,20] and 
selected mutants [21] to be involved in both allogeneic and antigen 
plus self stimulation. Thus, either of these sites would be good 
candidates for the location of the antigenic determinant. On the 
other hand, it is possible that TNP binding to the E molecule is 
not the critical stimulus for activation of this clone, but rather 
that TNP bound to another membrane molecule is recognized in 
association with Ef3 [22] . Detailed biochemical analyses are re-
quired to address these possibilities more fully . 
The pattern of responsiveness of clone SE-4 was different from 
that of D-S. The former proliferated in response to TNP-coupled 
SC bearing E~: E~ as well as to TNP-coupled SC bearing 
E~ : E~ and E~: E~ . In addition, SE-4 was not alloreactive to 
E~: E~. These results suggest that SE-4 is recognizing a different 
antigenic determinant than that seen by clone D-S. If this deter-
minant is also formed by direct coupling of TNP to the Ef3: E" 
Ia molecule, then the site would most likely be a lysine or tyrosine 
(exposed to solvent) that is found on E~, E~, and E~ but not found 
on E3. If the critical molecule is Ell' the best candidate position 
for this site is a tyrosine at position 31 (Table VII). 
The observation that both clones proliferate in response to TNP 
plus a self Ia molecule as well as TNP plus an allogeneic Ia mol-
ecule is unusual at the helper T-cell level [23]. This type of de-
generacy (cross-reactivity) in MHC restriction for antigen has 
been previously observed for pigeon cytochrome c-responsive T-
cell clones [24] . In this case there was also cross-reactivity between 
E~ and E~. The structural basis for this cross-reactivity is prob-
ably due to the fact that E~ and E~ differ by only 4 amino acids 
[15,16; P . Jones, personal communication)' 
The clones that are described in this report have, to date, been 
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utilized as responder cells in the assessment of potential antigen-
presenting function in the epidermis of mice undergoing graft-
versus-host disease or of mice that have been treated with various 
monoclonal alloantibodies [25,26] . In these studies they h ave pro-
vided a ready source of responder cells that are not contaminated 
with antigen-presenting cells that could potentially reprocess an-
tigen. The clones should also prove useful in determining the 
sequence of events that occur during T-cell recognition of hapten 
in association with MHC-encoded class II molecules. 
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